Status:
TERMINATED
Effectiveness of GastimunHp Plus in Supporting the Treatment of Peptic Ulcer Disease With Helicobacter Pylori Infection
Lead Sponsor:
Institute of Gastroenterology and Hepatology, Vietnam
Conditions:
Helicobacter Pylori Infection
Peptic Ulcer
Eligibility:
All Genders
10+ years
Phase:
NA
Brief Summary
Challenges in the treatment of Helicobacter pylori (H. pylori) include increasing antimicrobial resistance and patient's low tolerance to some regimens. Lactobacillus johnsonii (L. johnsonii) and Immu...
Eligibility Criteria
Inclusion
- Diagnosed with gastritis, duodenitis, or peptic ulcer.
- Tested positive with Helicobacter pylori using C13- or C14-urea breath test or urease test.
- Indicated for Helicobacter pylori eradication.
Exclusion
- Suspected malignant lesions.
- Children under 10 years of age; pregnant or lactating women.
- Allergic to chicken egg.
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2021
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT04025983
Start Date
November 1 2019
End Date
October 1 2021
Last Update
October 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Gastroenterology and Hepatology
Hanoi, Vietnam